Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16% - PRNewswire

Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16%  PRNewswire

NASHVILLE, Tenn., Feb. 26, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on ...



Comments

Popular posts from this blog

“Diagnosis and management of acute respiratory distress syndrome - CMAJ” plus 2 more